CD86 and leukemia: We made similar observations in primary patient MLL leukemia cells with upregulation of differentiation markers CD11b and CD86, reduced clonogenic activity, increased maturation of cells to mature macrophages (Fig. 1H–L; Table S4) and a G1 cell cycle arrest without significant enhancement of apoptosis (Fig. S1A, B).